CASINO GUICHARD PERRACHON (CO.PA)

FR001400OKR3 - Common Stock

1.0948  -0.01 (-0.58%)

Fundamental Rating

2

CO gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 30 industry peers in the Consumer Staples Distribution & Retail industry. CO may be in some trouble as it scores bad on both profitability and health. CO is valued expensive and it does not seem to be growing.



2

1. Profitability

1.1 Basic Checks

In the past year CO has reported negative net income.
In the past year CO has reported a negative cash flow from operations.
In the past 5 years CO always reported negative net income.
CO had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

CO's Return On Assets of -55.72% is on the low side compared to the rest of the industry. CO is outperformed by 96.55% of its industry peers.
CO's Return On Equity of -363.88% is on the low side compared to the rest of the industry. CO is outperformed by 96.55% of its industry peers.
Industry RankSector Rank
ROA -55.72%
ROE -363.88%
ROIC N/A
ROA(3y)-11.2%
ROA(5y)-8.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CO has a better Gross Margin (28.15%) than 72.41% of its industry peers.
In the last couple of years the Gross Margin of CO has grown nicely.
CO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 28.15%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.15%
GM growth 5Y2.07%

2

2. Health

2.1 Basic Checks

CO does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, CO has less shares outstanding
CO has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CO has a worse debt to assets ratio.

2.2 Solvency

CO has an Altman-Z score of -0.24. This is a bad value and indicates that CO is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.24, CO is doing worse than 96.55% of the companies in the same industry.
A Debt/Equity ratio of 2.10 is on the high side and indicates that CO has dependencies on debt financing.
With a Debt to Equity ratio value of 2.10, CO is not doing good in the industry: 93.10% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Altman-Z -0.24
ROIC/WACCN/A
WACC3.03%

2.3 Liquidity

A Current Ratio of 0.93 indicates that CO may have some problems paying its short term obligations.
CO has a Current ratio (0.93) which is comparable to the rest of the industry.
A Quick Ratio of 0.76 indicates that CO may have some problems paying its short term obligations.
CO has a Quick ratio of 0.76. This is amongst the best in the industry. CO outperforms 82.76% of its industry peers.
Industry RankSector Rank
Current Ratio 0.93
Quick Ratio 0.76

2

3. Growth

3.1 Past

The earnings per share for CO have decreased strongly by -147.51% in the last year.
Looking at the last year, CO shows a decrease in Revenue. The Revenue has decreased by -6.20% in the last year.
Measured over the past years, CO shows a very negative growth in Revenue. The Revenue has been decreasing by -23.64% on average per year.
EPS 1Y (TTM)-147.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.01%
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-34.7%
Revenue growth 5Y-23.64%
Sales Q2Q%-6.1%

3.2 Future

The Earnings Per Share is expected to grow by 26.01% on average over the next years. This is a very strong growth
Based on estimates for the next years, CO will show a very negative growth in Revenue. The Revenue will decrease by -13.71% on average per year.
EPS Next Y102.45%
EPS Next 2Y41.33%
EPS Next 3Y26.01%
EPS Next 5YN/A
Revenue Next Year-38.96%
Revenue Next 2Y-20.89%
Revenue Next 3Y-13.71%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for CO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CO's earnings are expected to grow with 26.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y41.33%
EPS Next 3Y26.01%

0

5. Dividend

5.1 Amount

CO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CASINO GUICHARD PERRACHON

EPA:CO (12/24/2024, 7:00:00 PM)

1.0948

-0.01 (-0.58%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupConsumer Staples Distribution & Retail
GICS IndustryConsumer Staples Distribution & Retail
Earnings (Last)10-31 2024-10-31
Earnings (Next)N/A N/A
Inst Owners8.06%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap438.95M
Analysts36.67
Price Target1.75 (59.85%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-70.47%
PT rev (3m)-70.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.03
P/FCF N/A
P/OCF N/A
P/B 0.28
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-5237.14
EYN/A
EPS(NY)-0.74
Fwd EYN/A
FCF(TTM)-1.12
FCFYN/A
OCF(TTM)-0.83
OCFYN/A
SpS33.1
BVpS3.85
TBVpS-2.76
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -55.72%
ROE -363.88%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 28.15%
FCFM N/A
ROA(3y)-11.2%
ROA(5y)-8.13%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.15%
GM growth 5Y2.07%
F-Score3
Asset Turnover1.32
Health
Industry RankSector Rank
Debt/Equity 2.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 33.52%
Cap/Sales 0.88%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.93
Quick Ratio 0.76
Altman-Z -0.24
F-Score3
WACC3.03%
ROIC/WACCN/A
Cap/Depr(3y)86.16%
Cap/Depr(5y)82.23%
Cap/Sales(3y)8.21%
Cap/Sales(5y)6.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-147.51%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%100.01%
EPS Next Y102.45%
EPS Next 2Y41.33%
EPS Next 3Y26.01%
EPS Next 5YN/A
Revenue 1Y (TTM)-6.2%
Revenue growth 3Y-34.7%
Revenue growth 5Y-23.64%
Sales Q2Q%-6.1%
Revenue Next Year-38.96%
Revenue Next 2Y-20.89%
Revenue Next 3Y-13.71%
Revenue Next 5YN/A
EBIT growth 1Y-284.41%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year958.88%
EBIT Next 3Y214.91%
EBIT Next 5YN/A
FCF growth 1Y-45200%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-122.78%
OCF growth 3YN/A
OCF growth 5YN/A